Colleen Macinnis, MD
MOHS-Micrographic Surgery · Leesburg, FLNPI 1700828290
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $134, 7.2 times the $18 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.
Across 16 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$61
- Kerecis Limited$52
- Galderma Laboratories, L.p.$49
- AbbVie$34
- Amgen$32
- Novartis$29
- plus $92 from 5 others
What the payments were for
- Food & beverage$33596%
- Education$134%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 1 | $61 |
| Kerecis Limited | 3 | $52 |
| Galderma Laboratories, L.p. | 3 | $49 |
| AbbVie | 1 | $34 |
| Amgen | 2 | $32 |
| Novartis | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Almirall LLC | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Biofrontera Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$348 in reported general payments places this provider in the 15th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 29 | $1,166 |
| Mupirocin | 153 | $1,106 |
| Doxycycline Hyclate | 20 | $310 |
| Triamcinolone Acetonide | 20 | $248 |
| Gabapentin | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Leesburg
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.